2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿|IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J PHARMACOL EXP THER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.6
51人评分
我要评分
声誉 8.6 影响力 6.4 速度 9.6 | |||||||||||||||||||||
| 期刊ISSN | 0022-3565 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1521-0103 | |||||||||||||||||||||
| 2024-2025最新影响因子 (数据来源于搜索引擎) | 3.8 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:4.01 | |||||||||||||||||||||
| 2024-2025自引率 | 0.0%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 3.5 | |||||||||||||||||||||
| JCI期刊引文指标 | 1.12 | |||||||||||||||||||||
| h-index | 209 | |||||||||||||||||||||
| CiteScore ( 2025年最新版) |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://jpet.aspetjournals.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://submit-jpet.aspetjournals.org/ | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Targeting cholangiocyte sphingosine-1-phosphate (S1P) receptor 1 signaling alleviates cholestatic liver injury: Mechanistic insight into S1P/phosphorylated signal transducer and activator of transcription 3 axis Author: Yuan, Zihang; Wang, Jie; Zhang, Haoran; Miao, Yingying; Chai, Yuanyuan; Li, Anqin; Tang, Qianhui; Chen, Qingyu; Zhang, Luyong; Yu, Qinwei; Jiang, Zhenzhou Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 4, pp. -. DOI: 10.1016/j.jpet.2026.104306 Multiomics and experimental validation reveal theophylline's mechanism targeting IL1A/ACTB/TLR4 and identify synergistic drugs in hepatocellular carcinoma Author: Gao, Yuxiang; Chen, Wei; Zarogoulidis, Paul; Yallapu, Murali M.; V. Nikolic, Milos; Vaishnani, Deep K.; Zheng, Jianjian; Nedeljkovic, Nikola; Ye, Kexin; Guo, Yong; Xu, Qiyu Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 3, pp. -. DOI: 10.1016/j.jpet.2026.103836 Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease (vol. 350, pg. 361, 2014) Author: Peng, Ying; Hu, Yanli; Xu, Shaofeng; Rong, Xianfang; Li, Jiang; Li, Pingping; Wang, Ling; Yang, Jinghua; Wang, Xiaoliang Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 1, pp. -. DOI: 10.1016/j.jpet.2025.103763 Alleviation of metabolic dysfunction-associated steatotic liver disease by silymarin is associated with maintaining mitochondrial homeostasis via regulation of optic atrophy 1 Author: Liu, Ming-qiang; Wu, Yuan; Li, Ye; Wei, Yan-bo; Dong, Ling-yue; An, Wei Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 7, pp. -. DOI: 10.1016/j.jpet.2025.103611 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS的语言要求,还能让JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS编辑和审稿人得到更好的审稿体验,让稿件最大限度地被JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇) 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3995 | |||||||||||||||||||||
| 出版商 | American Society for Pharmacology and Experimental Therapeutics | |||||||||||||||||||||
| 涉及的研究方向 | 医学-药学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 1909 | |||||||||||||||||||||
| 年文章数 | 1点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 21.89% | |||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 100.00% | |||||||||||||||||||||
| WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:2区
| |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-3565%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 平均1.0个月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 约37.5% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(1篇) 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Targeting cholangiocyte sphingosine-1-phosphate (S1P) receptor 1 signaling alleviates cholestatic liver injury: Mechanistic insight into S1P/phosphorylated signal transducer and activator of transcription 3 axis Author: Yuan, Zihang; Wang, Jie; Zhang, Haoran; Miao, Yingying; Chai, Yuanyuan; Li, Anqin; Tang, Qianhui; Chen, Qingyu; Zhang, Luyong; Yu, Qinwei; Jiang, Zhenzhou Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 4, pp. -. DOI: 10.1016/j.jpet.2026.104306 PubMed DOI |
| 2. | Multiomics and experimental validation reveal theophylline's mechanism targeting IL1A/ACTB/TLR4 and identify synergistic drugs in hepatocellular carcinoma Author: Gao, Yuxiang; Chen, Wei; Zarogoulidis, Paul; Yallapu, Murali M.; V. Nikolic, Milos; Vaishnani, Deep K.; Zheng, Jianjian; Nedeljkovic, Nikola; Ye, Kexin; Guo, Yong; Xu, Qiyu Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 3, pp. -. DOI: 10.1016/j.jpet.2026.103836 PubMed DOI |
| 3. | Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease (vol. 350, pg. 361, 2014) Author: Peng, Ying; Hu, Yanli; Xu, Shaofeng; Rong, Xianfang; Li, Jiang; Li, Pingping; Wang, Ling; Yang, Jinghua; Wang, Xiaoliang Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 1, pp. -. DOI: 10.1016/j.jpet.2025.103763 PubMed DOI |
| 4. | Alleviation of metabolic dysfunction-associated steatotic liver disease by silymarin is associated with maintaining mitochondrial homeostasis via regulation of optic atrophy 1 Author: Liu, Ming-qiang; Wu, Yuan; Li, Ye; Wei, Yan-bo; Dong, Ling-yue; An, Wei Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 7, pp. -. DOI: 10.1016/j.jpet.2025.103611 PubMed DOI |
| 5. | Hesperidin improves cardiac fibrosis induced by b-adrenergic activation through modulation of gut microbiota Author: Liu, Xia; Ju, Weiwei; Qiang, Erjiao; Li, Dongning; Liang, Qing; Guo, Meina; Yun, Weijing; Chen, Zhenzhen Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 6, pp. -. DOI: 10.1016/j.jpet.2025.103578 PubMed DOI |
| 6. | Enhanced negative modulation of urotensin II on cardiac function and [Ca2+]i regulation in a diabetic rat model: Insights into molecular and cellular mechanisms Author: Zhang, Xiaowei; Chen, Zhe; Cao, Jing; Zhou, Peng; Zhang, Zhi; Sun, Xiaoqiang; Liu, Yixi; Li, Tiankai; Cheng, Heng-Jie; Cheng, Che Ping Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 6, pp. -. DOI: 10.1016/j.jpet.2025.103594 PubMed DOI |
| 7. | Disulfiram activation of prostaglandin E2 synthesis: a novel antifibrotic mechanism in pulmonary fibrosis Author: Pei, Xiaolin; Zheng, Fangxu; Li, Yin; Li, Xiaobo; Lin, Zhoujun; Han, Xiao; Tian, Zhenhuan; Cao, Ke; Ren, Dunqiang; Li, Chenggang Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 6, pp. -. DOI: 10.1016/j.jpet.2025.103588 PubMed DOI |
| 8. | Follistatin-like protein 1: Implications for renal disease progression Author: Gao, Yiqi; Ren, Junyi; Peng, Haoyu; Nasser, Moussa Ide; Liu, Chi Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 5, pp. -. DOI: 10.1016/j.jpet.2025.103564 PubMed DOI |
| 9. | Enhanced efficiency of MHC class II tumor neoantigen vaccines with a novel CD4+T-cell helper epitope Author: Mao, Qiuli; Tian, Yahong; Yu, Qiumin; Chen, Lingxiao; Zhang, Li; Tong, Yue; Yao, Wenbing; Gao, Xiangdong; Tian, Hong Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 5, pp. -. DOI: 10.1016/j.jpet.2025.103570 PubMed DOI |
| 10. | Regulation of glucocorticoid receptor nuclear localization in prostate cancer cells Author: Chen, Guang; Lv, Shidong; Pascal, Laura E.; Wang, Zhou Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 5, pp. -. DOI: 10.1016/j.jpet.2025.103577 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共30条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室